26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. January 6-7, 1994. - Suppr | 超能文献

26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. January 6-7, 1994.

出版信息

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S223-83.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. January 6-7, 1994.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S223-83.

2

26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. January 6-7, 1994.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。1994年1月6日至7日。

J Am Coll Cardiol. 1994 Oct;24(4):845-99.

3

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。特别工作组4：系统性高血压。

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S268-70.

4

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第3工作组：肥厚型心肌病、心肌炎及其他心肌心包疾病和二尖瓣脱垂。

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S261-7.

5

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第4工作组：系统性高血压。

J Am Coll Cardiol. 1994 Oct;24(4):885-8. doi: 10.1016/0735-1097(94)90845-1.

6

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 5: coronary artery disease.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S271-5.

7

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease.

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S246-53.

8

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: arrhythmias.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第6工作组：心律失常

Med Sci Sports Exerc. 1994 Oct;26(10 Suppl):S276-83.

9

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.第26届贝塞斯达会议：关于确定心血管异常运动员参赛资格的建议。第3工作组：肥厚型心肌病、心肌炎及其他心肌心包疾病与二尖瓣脱垂

J Am Coll Cardiol. 1994 Oct;24(4):880-5. doi: 10.1016/0735-1097(94)90844-3.

10

26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 5: coronary artery disease.

J Am Coll Cardiol. 1994 Oct;24(4):888-92. doi: 10.1016/0735-1097(94)90846-x.

引用本文的文献

1

Prevalence of Cardiovascular Disorders Among Iranian Elite Athletes.伊朗精英运动员中心血管疾病的患病率。

Asian J Sports Med. 2016 May 11;7(2):e35826. doi: 10.5812/asjsm.35826. eCollection 2016 Jun.

2

Squash racquets. A review of physiology and medicine.壁球拍。生理学与医学综述。

Sports Med. 1997 Feb;23(2):130-8. doi: 10.2165/00007256-199723020-00005.